Physician profile
Daniel G Tobert
NPI 1790123875
$22,836.57
in general payments reported to CMS, 2019-2025
7 companies · $22K in 2025
The $22K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5.70 · 2022: $115 · 2023: $51.50 · 2024: $185 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $655 · Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,438.69 |
| Travel and Lodging | $654.93 |
| Food and Beverage | $621.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vb Spine LLC | $16,040.47 | 2025 | Yukon Oct Spinal System, Everest Spinal System, Monterey Al |
| Dilon Technologies, INC. | $6,375.00 | 2025 | Hemoblast Bellows |
| Icotec Medical INC. | $127.82 | 2024 | Vader Pedicle System |
| Stryker Corporation | $115.59 | 2022-2025 | Core |
| Nuvasive, INC. | $114.76 | 2022-2023 | Reline |
| Medtronic, INC. | $57.23 | 2024 | Cd Horizon Spinal System |
| Orthofix Medical, INC. | $5.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Tobert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.